Drugs / Avidin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06390241 | Jun 2024 → Jan 2025 | breast cancer | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00311090 | Apr 2006 → Jan 2008 | venous thromboembolism | Sanofi | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT00580216 Background | Dec 2007 → Oct 2010 | atrial fibrillation | Sanofi | Terminated | No outcome recorded Stop: Business |
| Phase 3 | NCT00345618 Background | Jun 2006 → Oct 2010 | pulmonary embolism, venous thromboembolism | Sanofi | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Avidin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00580216 ↗ |
| Known as | Avidin, chicken | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297569 ↗ |
| Route | Intravenous | “30-min intravenous avidin infusion” PMID 20088937 ↗ Jan 2010 |